
Trulieve praises Trump admin for moving marijuana to Schedule III, easing research barriers and removing 280E tax burden.
Reclassification of cannabis by the government has simplified the process for research and eliminated the harsh 280E tax implications. Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF), a prominent cannabis firm in the U.S., commends this development.

